Intellia Therapeutics (NTLA) Depreciation and Depletion (2015 - 2017)
Intellia Therapeutics (NTLA) reported Depreciation and Depletion of $660000.0 for Q1 2017, up 252.94% year-over-year from $187000.0 in Q1 2016, and up 64.59% quarter-over-quarter from $401000.0 in Q4 2016.
Intellia Therapeutics (NTLA) Depreciation and Depletion (2015 - 2017) Analysis & Trends
Intellia Therapeutics (NTLA) has 3 years of Depreciation and Depletion data on file, last reported at $660000.0 in Q1 2017.
- Depreciation and Depletion for Q1 2017 came in at $660000.0, up 252.94% year-over-year; the trailing twelve-month figure through Mar 2017 was $1.6 million (up 246.48% YoY), and the FY2017 annual result was $3.0 million, up 172.73% from the prior year.
- Depreciation and Depletion rose to $660000.0 in Q1 2017 per NTLA's latest filing, from $401000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $660000.0 in Q1 2017 and troughed at $33000.0 in Q1 2015.
- A 3-year average of $228888.9 and a median of $187000.0 in 2016 frame the typical range for Depreciation and Depletion.
- On a YoY basis, Depreciation and Depletion climbed as much as 466.67% in 2016 and fell as far as 176.04% in 2016.
- A 3-year view of Depreciation and Depletion shows it stood at $104000.0 in 2015, then jumped by 285.58% to $401000.0 in 2016, then surged by 64.59% to $660000.0 in 2017.
- Business Quant data shows NTLA's Depreciation and Depletion at $660000.0 in Q1 2017, $401000.0 in Q4 2016, and $265000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Intellia Therapeutics | 1.86 Bn | 1.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 660,000.00 |
| Mar 31, 2017 | 660,000.00 |
| Dec 31, 2016 | 401,000.00 |
| Dec 31, 2016 | 401,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Jun 30, 2016 | 247,000.00 |
| Jun 30, 2016 | 247,000.00 |
| Mar 31, 2016 | 187,000.00 |
| Mar 31, 2016 | 187,000.00 |
| Dec 31, 2015 | 104,000.00 |
| Dec 31, 2015 | 104,000.00 |
| Sep 30, 2015 | 96,000.00 |
| Sep 30, 2015 | 96,000.00 |
| Jun 30, 2015 | 67,000.00 |
| Jun 30, 2015 | 67,000.00 |
| Mar 31, 2015 | 33,000.00 |
| Mar 31, 2015 | 33,000.00 |